BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32194694)

  • 1. Overexpression of long non-coding RNA cancer susceptibility 11 is involved in the development of chemoresistance to carboplatin in hepatocellular carcinoma.
    Liu H; Liu T; Zhou Y; Song X; Wei R
    Oncol Lett; 2020 Mar; 19(3):1993-1998. PubMed ID: 32194694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p.
    Cheng N; Wu J; Yin M; Xu J; Wang Y; Chen X; Nie Z; Yin J
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression
    Chen F; Li M; Wang L
    Front Oncol; 2021; 11():772671. PubMed ID: 34900723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CASC11 in ovarian squamous cell carcinoma mediates the development of cancer cell resistance to chemotherapy.
    Shen F; Feng L; Zhou J; Zhang H; Xu Y; Jiang R; Zhang H; Chen Y
    Gene; 2019 Aug; 710():363-366. PubMed ID: 31181314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11.
    Su X; Zhang J; Luo X; Yang W; Liu Y; Liu Y; Shan Z
    Onco Targets Ther; 2019; 12():8117-8123. PubMed ID: 31632064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
    Han Y; Chen M; Wang A; Fan X
    Biochem Biophys Res Commun; 2019 Jan; 508(2):472-479. PubMed ID: 30503497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells.
    Chen F; Wang L
    Discov Oncol; 2023 Aug; 14(1):145. PubMed ID: 37552314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
    Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
    Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
    Luo H; Xu C; Le W; Ge B; Wang T
    J Cell Biochem; 2019 Aug; 120(8):13487-13493. PubMed ID: 30916832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer.
    Fu Y; Zhang P; Nan H; Lu Y; Zhao J; Yang M; Song Q
    Gene; 2019 Jul; 704():91-96. PubMed ID: 30965130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation.
    Song H; Liu Y; Li X; Chen S; Xie R; Chen D; Gao H; Wang G; Cai B; Yang X
    Clin Transl Med; 2020 Nov; 10(7):e220. PubMed ID: 33252856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotically-associated long non-coding RNA promotes cancer cell proliferation in hepatocellular carcinoma by downregulating miR-122a.
    Zhang X; Li H; Mao M; Wang X; Zheng J; Yang S
    Oncol Lett; 2019 Dec; 18(6):6237-6242. PubMed ID: 31788100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CASC11 promotes osteosarcoma metastasis by suppressing degradation of snail mRNA.
    Song K; Yuan X; Li G; Ma M; Sun J
    Am J Cancer Res; 2019; 9(2):300-311. PubMed ID: 30906630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CASC11 promotes the development of lung cancer through targeting microRNA-302/CDK1 axis.
    Tong W; Han TC; Wang W; Zhao J
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6539-6547. PubMed ID: 31378894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CASC11 Overexpression Predicts Poor Prognosis and Regulates Cell Proliferation and Apoptosis in Ovarian Carcinoma.
    Cui Y; Shen G; Zhou D; Wu F
    Cancer Manag Res; 2020; 12():523-529. PubMed ID: 32158258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
    Chen X; Wang L; Wang H
    Oncol Lett; 2019 Oct; 18(4):3811-3816. PubMed ID: 31516592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role for the long non-coding RNA
    Zheng L; Guan Z; Xue M
    Am J Transl Res; 2021; 13(9):10922-10932. PubMed ID: 34650773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
    Ouyang H; Zhang L; Xie Z; Ma S
    Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.